Polycystic Ovary Syndrome Profile (PCOS) at Chughtai Lab

Polycystic Ovary Syndrome Profile (PCOS) at Chughtai Lab

Polycystic Ovary Syndrome (PCOS) is a highly prevalent endocrine and metabolic disorder affecting women of reproductive age globally, with a significant impact on the female population in Pakistan. Characterized by a complex interplay of hormonal imbalances, ovulatory dysfunction, and metabolic abnormalities, PCOS requires a comprehensive diagnostic approach for effective clinical management. The Polycystic Ovary Syndrome Profile (PCOS Profile) at Chughtai Lab is a specialized panel of laboratory investigations meticulously designed to evaluate the physiological markers associated with this syndrome. This diagnostic profile integrates key hormone assays, metabolic indicators, and exclusionary tests to provide clinicians with a detailed assessment of a patient’s endocrine and metabolic health. By utilizing advanced automated immunoassay platforms and clinical chemistry analyzers, Chughtai Lab ensures highly precise, reproducible, and clinically actionable results.

The PCOS Profile is essential for establishing an accurate diagnosis under the Rotterdam criteria, which require at least two of three features: oligo- or anovulation, clinical and/or biochemical signs of hyperandrogenism, and polycystic ovaries on ultrasound. Beyond diagnosis, this profile plays a critical role in identifying underlying insulin resistance, assessing cardiovascular risk, and ruling out other endocrine disorders that mimic PCOS, such as thyroid dysfunction or hyperprolactinemia. For women experiencing irregular menstrual cycles, unexplained infertility, excessive facial hair, or persistent acne, the PCOS Profile at Chughtai Lab serves as a foundational diagnostic tool, enabling healthcare providers to design personalized therapeutic strategies, lifestyle interventions, and long-term health management plans to prevent complications like type 2 diabetes and endometrial hyperplasia.

Clinical Procedure: What to Expect

Patient Preparation

• Fasting Requirements: A strict fasting period of 10 to 12 hours is highly recommended before sample collection. This is because the PCOS Profile typically includes metabolic markers such as fasting blood glucose, fasting insulin, and a lipid profile, which require a fasting state for accurate measurement. Only plain water is permitted during this fasting window.
• Menstrual Cycle Timing: For menstruating women, the blood sample is ideally collected during the early follicular phase of the menstrual cycle, specifically between day 2 and day 5 of the cycle (where day 1 is the first day of menstrual bleeding). This timing is crucial for evaluating baseline gonadotropin (LH and FSH) levels.
• Medication Disclosure: Patients must inform their healthcare provider and the laboratory staff of all medications, supplements, and hormonal therapies they are currently taking. Certain medications, including oral contraceptives, metformin, spironolactone, and biotin supplements, can significantly interfere with hormone assay results.
• Hydration: Staying well-hydrated by drinking plain water is encouraged, as it facilitates easier venipuncture and does not affect the test results.

During the Procedure

• Patient Positioning: The patient is comfortably seated in a specialized phlebotomy chair. The phlebotomist will ask the patient to extend their arm, exposing the antecubital fossa (the inner elbow area).
• Site Selection and Cleansing: The phlebotomist will inspect the veins in the arm and select a suitable vein for venipuncture. A tourniquet is applied a few inches above the selected site to increase venous filling. The selected site is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) using a circular motion and allowed to air dry completely.
• Sample Collection: Using a sterile, single-use needle and vacuum collection tubes (such as serum separator tubes for hormones and fluoride/EDTA tubes for glucose), the phlebotomist performs the venipuncture. The required volume of blood is drawn into the tubes.
• Duration and Experience: The actual blood draw takes approximately 2 to 3 minutes. Patients may feel a brief, mild pinch as the needle enters the vein, but the procedure is generally well-tolerated and virtually painless.
• Post-Draw Care: Once the collection is complete, the tourniquet is released, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to prevent hematoma formation. A small adhesive bandage is then applied.
• Safety Considerations: Chughtai Lab adheres to strict biosafety protocols, using only sterile, disposable equipment to eliminate any risk of cross-contamination or infection.

When is a Polycystic Ovary Syndrome Profile (PCOS) Performed?

Irregular Menstrual Cycles and Ovulatory Dysfunction

Oligomenorrhea (infrequent periods) or amenorrhea (absence of menstruation) are primary clinical indicators for ordering a PCOS Profile. In women with PCOS, the normal feedback loop of the hypothalamic-pituitary-ovarian axis is disrupted. The pituitary gland secretes abnormally high levels of Luteinizing Hormone (LH) relative to Follicle-Stimulating Hormone (FSH). This hormonal imbalance prevents the normal development and maturation of ovarian follicles. Instead of a single dominant follicle maturing and releasing an egg during ovulation, multiple follicles arrest in early development, leading to chronic anovulation and irregular cycles. The PCOS Profile measures these gonadotropins to confirm ovulatory dysfunction and assess the severity of the hormonal imbalance.

Clinical Signs of Hyperandrogenism (Hirsutism and Acne)

Physicians frequently request the PCOS Profile when a patient presents with physical symptoms of androgen excess. These symptoms include hirsutism (excessive, coarse hair growth on the face, chin, chest, abdomen, or back), severe or treatment-resistant cystic acne, and androgenic alopecia (hair thinning or male-pattern baldness). These clinical manifestations are driven by elevated circulating levels of free androgens, which stimulate the sebaceous glands and hair follicles. The laboratory profile measures total testosterone, free testosterone, and dehydroepiandrosterone sulfate (DHEAS) to biochemically confirm hyperandrogenism, identify the source of excess androgens (ovarian vs. adrenal), and rule out androgen-secreting tumors.

Unexplained Female Infertility and Conception Difficulties

PCOS is the most common cause of anovulatory infertility in women. When a patient experiences difficulty conceiving after 12 months of regular, unprotected intercourse (or 6 months for women over 35), a comprehensive fertility workup is initiated. The PCOS Profile is a critical component of this evaluation. Chronic anovulation means that eggs are not regularly released, making natural conception highly challenging. Additionally, the altered hormonal environment, characterized by high LH and insulin levels, can negatively impact oocyte quality and endometrial receptivity, increasing the risk of early pregnancy loss. The profile helps reproductive specialists understand the endocrine barriers to fertility and plan appropriate ovulation induction therapies.

Suspected Insulin Resistance and Metabolic Disturbances

Insulin resistance is a key metabolic feature of PCOS, present in both lean and overweight individuals. It occurs when the body’s cells do not respond effectively to insulin, prompting the pancreas to produce more insulin (hyperinsulinemia). High insulin levels directly stimulate the ovarian theca cells to produce excess androgens and suppress the liver’s production of sex hormone-binding globulin (SHBG), worsening hyperandrogenism. Clinical signs of insulin resistance include central obesity, difficulty losing weight, and acanthosis nigricans (dark, velvety patches of skin around the neck, armpits, or groin). The PCOS Profile includes fasting insulin, fasting glucose, and a lipid profile to detect insulin resistance, assess cardiovascular risk, and screen for prediabetes or metabolic syndrome.

Differential Diagnosis of Ovulatory and Endocrine Disorders

Because the symptoms of PCOS overlap with several other endocrine disorders, a definitive diagnosis requires ruling out these mimicking conditions. Hypothyroidism or hyperthyroidism can cause menstrual irregularities and weight changes; hyperprolactinemia (elevated prolactin levels) can cause amenorrhea and galactorrhea; and non-classic congenital adrenal hyperplasia (NCCAH) can present with hirsutism and irregular periods. The PCOS Profile includes Thyroid Stimulating Hormone (TSH) and Prolactin as exclusionary markers. By evaluating these hormones alongside reproductive androgens, clinicians can confidently rule out thyroid and pituitary disorders, ensuring an accurate diagnosis of PCOS and preventing inappropriate treatment.

What Does a Polycystic Ovary Syndrome Profile (PCOS) Detect?

• Elevated Luteinizing Hormone (LH) levels, reflecting altered hypothalamic-pituitary-ovarian axis dynamics.
• Normal or slightly suppressed Follicle-Stimulating Hormone (FSH) levels.
• An elevated LH-to-FSH ratio (often greater than 2:1 or 3:1), which is highly characteristic of PCOS.
• Elevated Total Testosterone levels, indicating ovarian androgen overproduction.
• Elevated Free Testosterone levels, representing the biologically active fraction of testosterone.
• Decreased Sex Hormone-Binding Globulin (SHBG) levels, which leads to an increase in circulating free (active) androgens.
• An elevated Free Androgen Index (FAI), calculated from total testosterone and SHBG levels.
• Elevated Dehydroepiandrosterone Sulfate (DHEAS) levels, indicating an adrenal contribution to hyperandrogenism.
• Elevated Androstenedione levels, another key androgen precursor produced by both the ovaries and adrenal glands.
• Normal or mildly elevated Prolactin levels, helping to rule out prolactinoma or other pituitary pathology.
• Normal Thyroid Stimulating Hormone (TSH) levels, ruling out primary hypothyroidism or hyperthyroidism as the cause of menstrual irregularity.
• Elevated Fasting Insulin levels, indicating compensatory hyperinsulinemia.
• Elevated Fasting Blood Glucose levels, identifying impaired fasting glucose or impaired glucose tolerance.
• An elevated HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) score, confirming insulin resistance.
• Elevated Total Cholesterol levels, reflecting metabolic dysregulation.
• Elevated Low-Density Lipoprotein Cholesterol (LDL-C) levels, indicating an increased risk of cardiovascular disease.
• Decreased High-Density Lipoprotein Cholesterol (HDL-C) levels, commonly observed in metabolic syndrome.
• Elevated Triglyceride levels, associated with insulin resistance and atherogenic risk.
• Elevated Anti-Müllerian Hormone (AMH) levels, reflecting the high number of small antral follicles in the ovaries.
• Normal or elevated 17-Hydroxyprogesterone (17-OHP) levels, used to rule out non-classic congenital adrenal hyperplasia.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab utilizes advanced, fully automated immunoassay and clinical chemistry platforms to ensure rapid and highly accurate processing of the PCOS Profile. The turnaround time for this comprehensive panel is typically 24 to 48 hours from the time of sample collection. Once the results are verified by a Consultant Pathologist, patients receive an automated SMS notification. Reports can be accessed and downloaded digitally through the official Chughtai Lab website portal or the user-friendly My Chughtai mobile application. Physical copies of the report can also be collected from any Chughtai Lab diagnostic center or home-delivered upon request, ensuring seamless and convenient access for patients across Pakistan.

Polycystic Ovary Syndrome Profile (PCOS) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Luteinizing Hormone (LH)	1.9 – 12.5 mIU/mL (Follicular Phase)	Elevated (>12.5 mIU/mL or inverted LH:FSH ratio)
Follicle-Stimulating Hormone (FSH)	2.5 – 10.2 mIU/mL (Follicular Phase)	Normal or low-normal relative to LH
Total Testosterone	15 – 70 ng/dL	Elevated (>70 ng/dL, indicating hyperandrogenism)
Sex Hormone-Binding Globulin (SHBG)	18 – 144 nmol/L	Decreased (<18 nmol/L, increasing free testosterone)
DHEAS	Age-dependent (e.g., 80 – 340 ug/dL)	Elevated (suggesting adrenal androgen excess)
Fasting Insulin	<10 uIU/mL	Elevated (>10 uIU/mL, indicating insulin resistance)
Fasting Blood Glucose	70 – 99 mg/dL	Elevated (100-125 mg/dL prediabetes; >=126 mg/dL diabetes)
Thyroid Stimulating Hormone (TSH)	0.4 – 4.0 uIU/mL	Elevated (hypothyroidism) or Decreased (hyperthyroidism)
Prolactin	<25 ng/mL	Mildly elevated (25-50 ng/mL) or highly elevated (pituitary disorder)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Polycystic Ovary Syndrome Profile (PCOS)?

• ISO 15189 Certified Laboratories: Ensuring international standards of quality, accuracy, and reliability in clinical testing.
• College of American Pathologists (CAP) Participant: Demonstrating commitment to global proficiency and rigorous quality control.
• Expert Pathologists and Biochemists: Reports are reviewed and signed off by highly qualified consultant pathologists.
• State-of-the-Art Automated Analyzers: Utilizing advanced chemiluminescence technology for highly sensitive hormone assays.
• Convenient Home Sample Collection: Professional phlebotomists collect blood samples from the comfort of your home across Pakistan.
• Easy Digital Report Access: View and download reports instantly via the official website or the My Chughtai App.
• Nationwide Diagnostic Network: Accessible through hundreds of collection centers in Lahore, Karachi, Islamabad, and other cities.
• Patient-Centric Care: Dedicated to providing a comfortable, professional, and compassionate environment for all patients.